로딩 중…
지수 로딩 중…
Taysha Gene Therapies, Inc.
TSHA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$6.39+3.25%
2026-06-18
Price Chart
Taysha Gene Therapies, Inc.+148.68%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.84B |
| Revenue | $7M |
| Net Income | $-130M |
| Total Assets | $300M |
| Net Assets | $212M |
| Value | |
| P/B | 8.67x |
| P/S | 245.82x |
| FCF Yield | -6.12% |
| Profitability | |
| ROE | -61.28% |
| ROA | -43.24% |
| Op. Margin | -1774.37% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 41.71% |
| Total Debt | $18M |
| FCF | $-112M |
| Cash | $277M |
| Current Ratio | 14.04x |
| Performance | |
| 1Y Return | 148.68% |
| 1M Return | 23.14% |
| From 52W High | -12.45% |
| 1Y MDD | -31.13% |
| Trading | |
| Volume | 1,243,743 shares |
| Trading Value | $8M |
| Per Share | |
| EPS | $-0.34 |
| BPS | $0.77 |